Download PDF
1 / Pages

Other users also viewed these articles

Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on aerobic capacity in children with Cystic Fibrosis aged 6 to 11 years: Actual observations and clinical perspectives Margarita Pérez-Ruiz; Mats te Bos; Patricia Fernández García; Cristina de Manuel Gómez; Ana Morales-Tirado; Alejandro López-Neyra; Marta Ruiz de Valbuena Maíz; Margarita Rubio; Verónica Sanz-Santiago;
10.1016/j.arbres.2025.02.010
Role of Systemic Inflammatory Indices in the Prediction of Moderate to Severe Bronchopulmonary Dysplasia in Preterm Infants Ufuk Cakir; Cuneyt Tayman; Ali Ulas Tugcu; Duran Yildiz;
Arch Bronconeumol. 2023;59:216-22
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial Clara Martín-Ontiyuelo; Anna Rodó-Pin; Daniel Echeverría-Esnal; Mireia Admetlló; Xavier Duran-Jordà; Mariela Alvarado; Joaquim Gea; Esther Barreiro; Diego A. Rodríguez-Chiaradía;
Arch Bronconeumol. 2022;58:689-98